GridAI Technologies Corp.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 777 YAMATO ROAD, BOCA RATON, FL, 33431
Mailing Address 777 YAMATO ROAD, BOCA RATON, FL, 33431
Phone 561-589-7020
Fiscal Year End 1231
EIN 464993860
Financial Overview
FY2024
-$18.06M
Net Income
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 12, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 13, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 8-K Current report of material events | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
| 3 Initial insider ownership report | December 29, 2025 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
Material Events
8-K Strategy Change January 7, 2026
High Impact
- GridAI Technologies Corp. completed the unwinding/reversal of its previous acquisition of ImmunogenX, Inc. (Immuno LLC).
- All ownership in Immuno LLC has been transferred back to its original shareholders, making Immuno LLC no longer part of GridAI.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.